Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Olga S, Matlin"'
Autor:
Claire M. Spettell, Rishi J. Desai, Joshua J. Gagne, Olga S. Matlin, William H. Shrank, Mufaddal Mahesri, Tanuja Chitnis, Eimir Hurley, Sarah L. Minden, Angela Tong, Niteesh K. Choudhry
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 25:113-121
The approval of new oral disease-modifying drugs (DMDs), such as fingolimod, dimethyl fumarate (DMF), and teriflunamide, has considerably expanded treatment options for relapsing forms of multiple sclerosis (MS). However, data describing the use of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98008b9b4fc47a9e33b53d07c9e9ce73
https://doi.org/10.18553/jmcp.2019.25.1.113
https://doi.org/10.18553/jmcp.2019.25.1.113
Autor:
Alexis A. Krumme, Niteesh K. Choudhry, William H. Shrank, Julie C. Lauffenburger, Olga S. Matlin, Gregory Brill, Claire M. Spettell, Jessica M. Franklin
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 24:469-477
Efforts at predicting long-term adherence to medications have been focused on patients filling typical month-long supplies of medication. However, prediction remains difficult for patients filling longer initial supplies, a practice that is becoming
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd57f69e2640733211ea3c983fcbad55
https://doi.org/10.18553/jmcp.2018.24.5.469
https://doi.org/10.18553/jmcp.2018.24.5.469
Autor:
Amanda McCarthy, Brooke Byrd, Lucia Feczko, Rashmi Grover, Elisea Avalos-Reyes, Dipti Shah, Olga S. Matlin
Publikováno v:
Journal of Clinical Oncology. 39:e13016-e13016
e13016 Background: According to the National Cancer Institute, breast cancer is the most common form of cancer in the United States. Nearly 75% of patients with breast cancer have tumors that are hormone receptor (HR)-positive and human epidermal gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eed037704e1426f7879c990d38f9d6ea
https://doi.org/10.1200/jco.2021.39.15_suppl.e13016
https://doi.org/10.1200/jco.2021.39.15_suppl.e13016
Autor:
Janice M. Moore, Troyen A. Brennan, Olga S. Matlin, William H. Shrank, Michael Gagnon, Pavlo Kyrychenko, Joshua W. Fredell, Jennifer M. Polinski
Publikováno v:
Health Affairs. 35:1222-1229
Adverse drug events and the challenges of clarifying and adhering to complex medication regimens are central drivers of hospital readmissions. Medication reconciliation programs can reduce the incidence of adverse drug events after discharge, but evi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d91eb1a7951cad3c7f120bab176dffc
https://doi.org/10.1377/hlthaff.2015.0648
https://doi.org/10.1377/hlthaff.2015.0648
Autor:
Alexis A. Krumme, Daniel H. Solomon, Olga S. Matlin, William H. Shrank, Gregory Brill, Jeffrey A. Sparks, Niteesh K. Choudhry, Edmund J. Pezalla
Publikováno v:
Arthritis & Rheumatology. 68:1588-1595
Objective Several trials suggest that triple therapy (methotrexate, sulfasalazine, and hydroxychloroquine) and biologic disease-modifying antirheumatic drugs (DMARDs) have similar efficacy in patients with rheumatoid arthritis (RA). This study was un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::943842a5d08c3b7b9b852ac0ef7e0112
https://doi.org/10.1002/art.39617
https://doi.org/10.1002/art.39617
Autor:
Danya M. Qato, Becky L. Genberg, Yoojin Lee, David D. Dore, David Hutchins, Olga S. Matlin, William H. Rogers, Ira B. Wilson, Troyen A. Brennan
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:790-797
Purpose The objective of this study was to determine the fraction of variance in patient-level medication adherence accounted for by prescribers and pharmacies. Methods We used prescription drug claims paid between January 2010 and July 2011 to a nat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eaaf0d719765976b652f6c716b12529
https://doi.org/10.1002/pds.4025
https://doi.org/10.1002/pds.4025
Autor:
Steven M. Kymes, Surya C. Singh, Alan M. Lotvin, William H. Shrank, Olga S. Matlin, Troyen A. Brennan, Pavlo Kyrychenko, Randy Falkenrath, Janice M. Moore
Publikováno v:
Journal of the American Pharmacists Association. 56:47-53
Background A new service model integrates the specialty pharmacy's comprehensive service with the retail pharmacy's patient contact, giving patients options for medication delivery to home, pharmacy, or doctor's office. Objective Evaluate the impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e9e459ea208258a876501d21f515f9
https://doi.org/10.1016/j.japh.2015.11.003
https://doi.org/10.1016/j.japh.2015.11.003
Autor:
Troyen A. Brennan, Albert W. Wu, William H. Shrank, Joy L. Lee, Olga S. Matlin, Niteesh K. Choudhry
Publikováno v:
Journal of General Internal Medicine. 31:45-51
Background Patient–physician communication often occurs outside the clinic setting; many institutions discourage electronic communication outside of established electronic health record systems. Little empirical data are available on patient intere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::055f863f9d4428c5ab7a59888e544b43
https://doi.org/10.1007/s11606-015-3374-7
https://doi.org/10.1007/s11606-015-3374-7
Autor:
Angela Y. Tong, Niteesh K. Choudhry, Olga S. Matlin, Jessica M. Franklin, Alexis A. Krumme, William H. Shrank, Troyen A. Brennan
Publikováno v:
Pharmacoepidemiology and Drug Safety. 24:1105-1113
Purpose Trajectory models have been shown to (1) identify groups of patients with similar patterns of medication filling behavior and (2) summarize the trajectory, the average adherence in each group over time. However, the association between adhere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07aa5bb880d55573353654cef880e373
https://doi.org/10.1002/pds.3787
https://doi.org/10.1002/pds.3787
Autor:
Olga S. Matlin, William H. Shrank, Troyen A. Brennan, Mehdi Najafzadeh, Karin L. Andersson, Alexis A. Krumme, Jerry Avorn, Niteesh K. Choudhry
Publikováno v:
Annals of Internal Medicine. 162:407-419
New regimens for hepatitis C virus (HCV) have shorter treatment durations and increased rates of sustained virologic response compared with existing therapies but are extremely expensive.To evaluate the cost-effectiveness of these treatments under di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd6341d66642b8b37d4a7bf9621fb97
https://doi.org/10.7326/m14-1152
https://doi.org/10.7326/m14-1152